STERIS plc logo
STESTERIS plc

Return on Equity (ROE): 10.89%

Is the return on equity (ROE) high or low?

The return on equity (ROE) of 10.89% is 56% above its 5-year average of 7.00%, near the high end of its 5-year range (1.76%–10.93%).

As of Friday, June 26, 2026. 7.61% above its 12-month average of 10.12%.

STE Return on Equity (ROE)

STE Return on Equity (ROE) Chart

10.93%

Annual fiscal-year return on equity; no daily interpolation.

+198.63% 10Y
STE Return on Equity (ROE)

STE Average Return on Equity (ROE) Chart

STE Return on Equity (ROE)

STE Current vs Average Return on Equity (ROE) Chart

STE Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

10.89%

RETURN ON EQUITY (ROE) AVG TTM

10.12%

RETURN ON EQUITY (ROE) AVG 3Y

7.00%

RETURN ON EQUITY (ROE) AVG 5Y

7.00%

RETURN ON EQUITY (ROE) AVG 10Y

7.29%

RETURN ON EQUITY (ROE) AVG 15Y

9.08%

RETURN ON EQUITY (ROE) AVG 20Y

9.95%

CURRENT VS TTM AVG

+7.61%

CURRENT VS 3Y AVG

+55.57%

CURRENT VS 5Y AVG

+55.68%

CURRENT VS 10Y AVG

+49.42%

CURRENT VS 15Y AVG

+19.97%

CURRENT VS 20Y AVG

+9.50%

STE Competitors' Return on Equity (ROE)

NAMEMARKET CAPRETURN ON EQUITY (ROE)TTM3Y5Y
STERIS plc (STE)$20.52B10.89%10.12%7.00%7.00%
Incyte Corporation (INCY)vs ›$21.48B25.79%12.92%11.29%9.83%
Labcorp Holdings Inc. (LH)vs ›$21.83B10.79%9.71%9.35%12.84%
Viatris Inc. (VTRS)vs ›$18.71B-2.02%-13.64%-4.29%-4.38%
BioNTech SE (BNTX)vs ›$22.76B-6.79%-4.55%10.63%21.70%
Quest Diagnostics Incorporated (DGX)vs ›$22.83B13.90%13.34%14.07%18.07%
United Therapeutics Corporation (UTHR)vs ›$23.07B21.82%18.68%17.25%16.03%
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$17.60B6.01%6.40%5.73%4.16%
Moderna, Inc. (MRNA)vs ›$23.71B-43.12%-32.64%-13.90%0.25%
Hologic, Inc. (HOLX)vs ›$16.97B10.37%13.30%15.60%24.66%

Return Analysis

ROE

10.9%

ROA

7.3%

Return on Equity (ROE) Formula & Definition

ROE = Net Income / Total Shareholders' Equity

Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for STERIS plc (STE)?
The return on equity (ROE) for STE stock is 10.89%.
Is STERIS plc's return on equity (ROE) high or low?
The return on equity (ROE) of 10.89% is 56% above its 5-year average of 7.00%, near the high end of its 5-year range (1.76%–10.93%).
What is the TTM average return on equity (ROE) for STERIS plc (STE)?
The TTM average return on equity (ROE) for STE stock is 10.12%.
What is the 3Y average return on equity (ROE) for STERIS plc (STE)?
The 3Y average return on equity (ROE) for STE stock is 7.00%.
What is the 5Y average return on equity (ROE) for STERIS plc (STE)?
The 5Y average return on equity (ROE) for STE stock is 7.00%.
What is the 10Y average return on equity (ROE) for STERIS plc (STE)?
The 10Y average return on equity (ROE) for STE stock is 7.29%.
What is the 15Y average return on equity (ROE) for STERIS plc (STE)?
The 15Y average return on equity (ROE) for STE stock is 9.08%.
What is the 20Y average return on equity (ROE) for STERIS plc (STE)?
The 20Y average return on equity (ROE) for STE stock is 9.95%.

STE Return on Equity (ROE) History

DATERETURN ON EQUITY (ROE)
2026-03-3110.93%
2025-03-319.31%
2024-03-316.00%
2023-03-311.76%
2022-03-313.73%
2021-03-3110.24%
2020-03-3111.97%
2019-03-319.57%
2018-03-319.07%
2017-03-313.93%
2016-03-313.66%
2015-03-3112.60%
2014-03-3112.46%
2013-03-3116.93%
2012-03-3116.57%
2011-03-316.51%
2010-03-3117.04%
2009-03-3115.42%
2008-03-3110.92%
2007-03-3110.61%
2006-03-319.62%
2005-03-3111.38%
2004-03-3113.85%
2003-03-3113.95%
2002-03-319.48%
2001-03-310.31%
2000-03-312.49%
1999-03-3119.48%
1998-03-3118.25%
1997-03-31-10.38%

About STERIS plc

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Mentor, OH
17,840 employees
Healthcare / Medical - Equipment & Services
Sector
Healthcare
Industry
Medical - Equipment & Services
CEO
Daniel A. Carestio